Clinical utility of the Mood and Anxiety Symptom Questionnaire (MASQ) in a sample of young help-seekers.
Clinical utility of the Mood and Anxiety Symptom Questionnaire (MASQ) in a sample of young help-seekers.
复制标题
年轻帮助者样本中的情绪和焦虑症状问卷（MASQ）的临床实用性。
DOI：
10.1186/1471-244x-7-50
复制
发表时间：
2007-09-17
期刊：
影响因子：
4.4
通讯作者：
Killackey, Eoin J.
中科院分区：
文献类型：
--
作者：
Buckby, Joe A.;Yung, Alison R.;Cosgrave, Elizabeth M.;Killackey, Eoin J.
抑郁和焦虑之间的重叠导致一些研究人员得出结论，它们是一种广泛的非特异性神经症的表现。然而，其他人认为，尽管他们有共同的一般痛苦症状，但他们可以区分开来。情感的三方模型提出了一个焦虑特异性，抑郁特异性和共同症状的因素。沃森和克拉克开发了情绪和焦虑症状问卷（MASQ），专门测量这些三方结构。早期的研究表明，MASQ在非临床样本中区分了抑郁和焦虑的维度。然而，最近的两项研究警告说，MASQ可能在临床人群中显示出有限的有效性。本研究调查了MASQ在青少年和年轻人临床样本中的临床实用性。在澳大利亚墨尔本，共有204名连续转介到专科公共精神卫生服务机构的年轻人被接触，150人同意参加。其中，136名参与者完成了诊断访谈和MASQ。大多数样本被评定为Axis-I障碍，其中情绪和焦虑障碍最常见。MASQ的疾病特异性量表显著区分焦虑（61.0%）和情绪障碍（72.8%），但焦虑障碍的预测准确率很低（29.8%）。从ROC分析，提出了一个建议的截止值为76抑郁量表，以表明情绪障碍的“病例”。所得灵敏度/特异性优于CES-D的灵敏度/特异性上级。研究结果表明，抑郁特异性量表的MASQ显示出良好的临床实用性，但焦虑特异性量表显示出较差的判别效度。
The overlap between Depression and Anxiety has led some researchers to conclude that they are manifestations of a broad, non-specific neurotic disorder. However, others believe that they can be distinguished despite sharing symptoms of general distress. The Tripartite Model of Affect proposes an anxiety-specific, a depression-specific and a shared symptoms factor. Watson and Clark developed the Mood and Anxiety Symptom Questionnaire (MASQ) to specifically measure these Tripartite constructs. Early research showed that the MASQ distinguished between dimensions of Depression and Anxiety in non-clinical samples. However, two recent studies have cautioned that the MASQ may show limited validity in clinical populations. The present study investigated the clinical utility of the MASQ in a clinical sample of adolescents and young adults. A total of 204 Young people consecutively referred to a specialist public mental health service in Melbourne, Australia were approached and 150 consented to participate. From this, 136 participants completed both a diagnostic interview and the MASQ. The majority of the sample rated for an Axis-I disorder, with Mood and Anxiety disorders most prevalent. The disorder-specific scales of the MASQ significantly discriminated Anxiety (61.0%) and Mood Disorders (72.8%), however, the predictive accuracy for presence of Anxiety Disorders was very low (29.8%). From ROC analyses, a proposed cut-off of 76 was proposed for the depression scale to indicate 'caseness' for Mood Disorders. The resulting sensitivity/specificity was superior to that of the CES-D. It was concluded that the depression-specific scale of the MASQ showed good clinical utility, but that the anxiety-specific scale showed poor discriminant validity.